News
Drug could improve treatment of CML, team says
A microRNA-targeting drug could improve the effectiveness of tyrosine kinase inhibitors (TKIs) against chronic myelogenous leukemia (CML),...
News
Giving patients control of their healthcare data
The US Centers for Medicare & Medicaid Services (CMS) has announced new initiatives designed to give patients control of their healthcare data...
News
Method may predict relapse at BCP-ALL diagnosis
Researchers say they have developed a technique that can help them determine, at diagnosis, whether children with B-cell precursor acute...
News
PK dosing software available in US
Pharmacokinetic (PK) dosing software intended for use in patients with hemophilia A is now available in the US. This free, web-based,...
News
Agent can reveal HSC engraftment faster
An imaging agent can safely show engraftment of hematopoietic stem cells (HSCs) just days after transplant, according to research published in The...
News
Drug approved to treat newly diagnosed MM in China
The China Food and Drug Administration (CFDA) has approved lenalidomide (Revlimid®) to treat patients with newly diagnosed multiple myeloma (MM...
News
Potential link between varicose veins and VTE, PAD
People with varicose veins may have an increased risk of venous thromboembolism (VTE) and peripheral artery disease (PAD), according to a new...
News
EC approves emicizumab for hemophilia A with inhibitors
The European Commission (EC) has granted marketing authorization for emicizumab (Hemlibra®), a bispecific factor IXa- and factor X-directed...
News
Use of RBC, plasma transfusions may be declining in US
A study of US hospital discharges revealed a decrease in the use of red blood cell (RBC) and plasma transfusions—but not platelet transfusions—in...
News
CHMP recommends approval for GO in AML
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for gemtuzumab...
News
Company withdraws application for idelalisib
Gilead Sciences International Ltd.
News
CHMP endorses drug delivery system
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended a label variation for Neulasta® (...
News
CHMP backs bosutinib for newly diagnosed CML
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the approved use of bosutinib (...
News
CHMP supports approval of denosumab in MM
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the current indication for...
News
Exercise doesn’t offset VTE risk from TV viewing
Getting the recommended amount of physical activity does not eliminate the increased risk of venous thromboembolism (VTE) associated with frequent...